The effect of an oral ginger supplementation on NF-κB concentration in peripheral blood mononuclear cells and anthropomorphic data of patients with type 2 diabetes: A randomized double-blind, placebo-controlled clinical trial.


Journal

Complementary therapies in medicine
ISSN: 1873-6963
Titre abrégé: Complement Ther Med
Pays: Scotland
ID NLM: 9308777

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 29 07 2018
revised: 13 10 2018
accepted: 23 10 2018
entrez: 24 1 2019
pubmed: 24 1 2019
medline: 3 5 2019
Statut: ppublish

Résumé

The complications of diabetes are extensive which can be caused by excessive oxidative stress, inflammation and impaired insulin system. Plant-sourced bioactive compounds can reduce inflammation and oxidative stress. The aim of present study was to determine the effect of ginger supplementation on diabetic complications. The present study is a randomized double blind clinical trial which is conducted with 48 diabetic patients. The participants were randomly divided into two intervention and placebo groups which were received 2 g ginger powder and 2 g wheat flour respectively for 10 weeks. Nuclear factor kappa B (NF-κB) concentration and anthropometric measurements were evaluated at the baseline and at the end of study. The effect of ginger supplementation on hip circumference was marginal and there was no significant effect on BMI and waist circumference. Mean NF-κB p65 concentrations were reduced in ginger supplementation group, however, the amount was not statistically significant. Ginger supplementation had significant effects on anthropometric evaluations. Ginger supplementation decreased mean NF-κB concentration in comparison with placebo, however the significance level was marginal. In order to achieve reliable information, more researches should be complemented with uptake of other diagnostic tools.

Identifiants

pubmed: 30670285
pii: S0965-2299(18)30751-9
doi: 10.1016/j.ctim.2018.10.019
pii:
doi:

Substances chimiques

NF-kappa B 0
Plant Extracts 0
Transcription Factor RelA 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-11

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Niyaz Mohammadzadeh Honarvar (N)

Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: niama80@yahoo.com.

Meysam Zarezadeh (M)

Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: meysam.za93@gmail.com.

Masoud Khorshidi (M)

Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: Khorshidi.2065@gmail.com.

Motahareh Makhdoomi Arzati (M)

Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: mmakhdomi68@yahoo.com.

Mir Saeed Yekaninejad (MS)

Department of Biostatistics and Epidemiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: yekaninejad@tums.ac.ir.

Mina Abdollahi (M)

AmirAlam Hospital Complex, Marvasti Hospital, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: abdolahimina.n@gmail.com.

Mohammad Effatpanah (M)

School of Medicine, Ziaeian Hospital, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: m-effatpanah@tums.ac.ir.

Rezvan Hashemi (R)

Department of Geriatric Medicine, Ziaeian Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: Rezvanum@yahoo.com.

Ahmad Saedisomeolia (A)

Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: a_saedi@tums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH